D
40
-5
SHW
68
-5
UNP
45
-3
HAS
33
-2
AIG
39
-5
LB
67
15
HCP
76
-2
LOW
56
-3
VRTX
57
-6
PLD
48
-2
M
31
-2
EXC
41
-2
LYB
37
-2
PPG
60
-4
GILD
60
-3
PH
78
-2
IRM
41
-3
SYK
73
5
DD
57
-4
HOG
33
-3
D
40
-5
SHW
68
-5
UNP
45
-3
HAS
33
-2
AIG
39
-5
LB
67
15
HCP
76
-2
LOW
56
-3
VRTX
57
-6
PLD
48
-2
M
31
-2
EXC
41
-2
LYB
37
-2
PPG
60
-4
GILD
60
-3
PH
78
-2
IRM
41
-3
SYK
73
5
DD
57
-4
HOG
33
-3
Financhill
Back

Cellectar Biosciences Vs. Marinus Pharmaceuticals Industry Stock Comparison

Sell
47

CLRB
Cellectar Biosciences

Last Price:
2.08
Seasonality Move:
-2.36%
Sell
34

MRNS
Marinus Pharmaceuticals

Last Price:
0.31
Seasonality Move:
14.27%
Sell
47
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.14. The Score for CLRB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $0.34. The Score for MRNS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 58.34 Buy
Chaikin Money Flow: 136682 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.12) Buy
Bollinger Bands (100): (1.95 - 2.43) Sell

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 25.64 Sell
Chaikin Money Flow: -229271 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 1.66) Sell
Bollinger Bands (100): (0.87 - 1.73) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.08 Buy
20-day SMA: 2.07 Buy
50-day SMA: 2.08 Buy
200-day SMA: 2.82 Sell
8-day EMA: 2.1 Buy
20-day EMA: 2.08 Buy
50-day EMA: 2.12 Buy
200-day EMA: 2.48 Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.34 Buy
20-day SMA: 0.77 Sell
50-day SMA: 1.28 Sell
200-day SMA: 3.45 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.68 Sell
50-day EMA: 1.08 Sell
200-day EMA: 2.96 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):